PRN Meeting: August 20, 2024 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President & Program Planner, Physicians' Research Network

Moderator: William M. Valenti, MD, FIDSA, Senior VP for Strategic Advancement, Chief of Innovation, Co-Founder, and Staff Physician, Trillium Health (Rochester, NY)

Guest Speakers and Presentations:

News from AIDS 2024 (Munich) on HIV Prevention and Cure, STIs, and Coinfections

Jürgen Rockstroh, MD

Head of Infectious Diseases
University Hospital Bonn (Germany)

At the completion of this educational activity learners will:
1. Be aware of new developments in the HIV prevention space including the use of long-acting regimens for PrEP.
2. Be familiar with the new WHO HBV guidelines and appreciate the current advances and challenges in TB and hepatitis coinfection
3. Be aware of new resistance and diagnostic trends in STIs also after introduction of doxyPEP.
4. Appreciate a potential new HIV cure case from Berlin.

More News from AIDS 2024 (Munich) on Antiretroviral Therapy, Cardiometabolic Health, and Anal Cancer Screening

Tristan J. Barber, MA, MD, FRCP

Consultant Physician, Ian Charleson Day Centre, Royal Free Hospital Honorary
Associate Professor, Institute for Global Health
University College London (United Kingdom)

At the completion of this educational activity learners will:
1. Understand updated approaches to anal cancer screening, and the role of high risk HPV in people with HIV.
2. Appreciate the global role of dolutegravir, the significance of resistance testing for integrase inhibitors, and how to best way to sequence from TLD with limited monitoring.
3. Consider the impact of new data on cardiometabolic health and weight gain.
4. Be aware of current approaches and issues arising in providing holistic HIV care for trans individuals and communities.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York designates this live activity for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statements:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Program Planner) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Gilead and ViiV. All relevant financial relationships have been mitigated.
- Dr. Jürgen Rockstroh, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Boehringer, MSD and ViiV; Advisor to Gilead and AbbVie; Speaker at Gilead, Janssen, MSD and ViiV. Dr. Rockstroh submitted his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.
- Dr. Tristan J. Barber, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Gilead, Janssen, Merck and ViiV. Dr. Barber submitted his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.